Results 21 to 30 of about 64,707 (235)

Post-Merge Carbon Footprint Analysis and Sustainability in the NFT Art Market

open access: yesArts, 2023
The market for non-fungible token (NFT) art is expected to reach USD 44.2 billion in 2021 and increase by 67.57 percent in 2022, revolutionizing the relationship between artists, collectors, and investors.
Zhongbo Tian
doaj   +1 more source

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease [PDF]

open access: yes, 2005
We have recently reported that a polymorphism in the cell division cycle (CDC2) gene, designated Ex6 + 7I/D, is associated with Alzheimer's disease (AD). The CDC2 gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD.
Andreasen N   +42 more
core   +1 more source

Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans

open access: yesPharmaceutics, 2023
Nitrofurantoin (NFT) is a commonly used antibiotic for the treatment of urinary tract infections that can cause liver toxicity. Despite reports of hepatic adverse events associated with NFT exposure, there is still limited understanding of the interplay ...
Raju Prasad Sharma   +2 more
doaj   +1 more source

Investigating the ownership relationship between virtual real estate owners and platform owners: An examination of the Decentraland metaverse [PDF]

open access: yesTaḥqīqāt-i Farhangī-i Īrān, 2023
Decentraland is a user-owned digital realm built on the Ethereum block chain that allows the global community to engage in, connect, and enjoy its immersive experience.
B. Ahmadvand, A. Jahanshahi
doaj   +1 more source

NFT Bubbles

open access: yesSSRN Electronic Journal, 2023
By investigating nonfungible tokens (NFTs), we provide the first systematic study of retail investor behavior through asset bubbles. Given that NFTs are recorded in public blockchains, we are able to track investor behavior over time, leading to the identification of numerous price run-ups and crashes. Our study reveals that agent-level variables, such
Barbon, Andrea, Ranaldo, Angelo
openaire   +4 more sources

Connect2NFT: A Web-Based, Blockchain Enabled NFT Application with the Aim of Reducing Fraud and Ensuring Authenticated Social, Non-Human Verified Digital Identity

open access: yesMathematics, 2022
As of 2022, non-fungible tokens, or NFTs, the smart contract powered tokens that represent ownership in a specific digital asset, have become a popular investment vehicle.
Jagger Bellagarda, Adnan M. Abu-Mahfouz
doaj   +1 more source

Meta‐Virtuality: Strategies of Disembeddedness in Virtual Interiorities

open access: yesJournal of Interior Design, EarlyView., 2022
ABSTRACT To reclaim their seat in the rapidly growing market of virtual space, designers of the built environment can benefit from reevaluating theories that see the virtual as a mere extension/reflection of the physical. By claiming ontological autonomy from external worlds, the virtual is liberated from the hegemonic control of the physical.
Vahid Vahdat
wiley   +1 more source

Complete Symmetry in D2L Systems and Cellular Automata [PDF]

open access: yes, 1985
We introduce completely symmetric D2L systems and cellular automata by means of an additional restriction on the corresponding symmetric devices. Then we show that completely symmetric D2L systems and cellular automata are still able to simulate Turing ...
Asveld, Peter R.J.
core   +7 more sources

Brain–computer interface game applications for combined neurofeedback and biofeedback treatment for children on the autism spectrum [PDF]

open access: yes, 2014
Individuals with Autism Spectrum Disorder (ASD) show deficits in social and communicative skills, including imitation, empathy, and shared attention, as well as restricted interests and repetitive patterns of behaviors.
Friedrich, Elisabeth V. C.   +5 more
core   +4 more sources

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy [PDF]

open access: yesJ Pathol Clin Res
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Nasdala A   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy